Table 4:
Mediation of intervention effects on anxiety symptom reduction by antidepressant use among patients with at least moderate anxiety symptoms in a trial of a collaborative care model for treatment of depression and diabetes in India (n=172)
RD | SE | p | |
---|---|---|---|
Intervention → anti-depressant use | |||
6 months | 0.18 | 0.06 | <0.001 |
12 months | 0.20 | 0.05 | <0.001 |
18 months | 0.07 | 0.05 | 0.20 |
24 months | 0.00 | 0.05 | 0.95 |
| |||
Anti-depressant use → anxiety symptom reduction | 0.05 | 0.04 | 0.10 |
| |||
Average causal mediation effect | 0.005 | 0.005 | 0.32 |
| |||
Direct effect | 0.108 | 0.03 | 0.002 |
| |||
Total effect | 0.113 | 0.03 | <0.001 |
| |||
% Mediated | 4.0% | 5.5% | 0.47 |
Abbreviations: RD, risk difference. SE, standard error.
Footnotes: Bold text indicates statistically significant estimate (p < 0.05).